Addiction, dopamine, and the molecular mechanisms of memory

Neuron

Volumn 25, Issue 3, 2000, Pages 515-532

  Berke, Joshua D ^a   Hyman, Steven E ^a,b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DOPAMINE; MORPHINE; NICOTINE;

ANIMAL EXPERIMENT; BRAIN REGION; COMPULSION; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; DRUG TOLERANCE; IMMEDIATE EARLY GENE; LEARNING; MEMORY; MOUSE; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0033695676     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)81056-9     Document Type: Review

References (285)

1. Loss of haloperldol-induced gene expression and catalepsy in protein kinase A-deficient mice
2. Transition from moderate to excessive drug intake: Change in hedonic set point
3. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions
4. The biological, social and clinical bases of drug addiction: Commentary and debate
5. Sensitization to the psychomotor stimulant effects of amphetamine: Modulation by associative learning
6. Involvement of the caudal striatum in auditory processing: c-fos Response to cortical application of picrotoxin and to auditory stimulation
7. The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment
8. Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: Modulation by environmental novelty
9. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors
10. Structural changes accompanying memory storage
11. Goal-directed instrumental action: Contingency and incentive learning and their cortical substrates
12. Adaptive critics and the basal ganglia
13. Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning
14. Dopamine D1-like receptors and reward-related incentive learning
15. A complex program of striatal gene expression induced by dopaminergic stimulation
16. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum
17. Competing motivations: Drug reinforcement vs non-drug reinforcement
18. Dopamine functions in appetitive and defensive behaviours
19. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa
20. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein
21. Homer: A protein that selectively binds metabotropic glutamate receptors
22. Acute effects of cocaine on human brain activity and emotion
23. Classical conditioning of cocaine's stimulatory effects
24. Cocaine-induced conditioned locomotion: Absence of associated increases in dopamine release
25. What do the basal ganglia do?
26. Behavioral sensitization to cocaine, but not cocaine-conditioned behavior, is associated with increased dopamine occupation of its receptors in the nucleus accumbens
27. Involvement of the amygdala in stimulus-reward associations: Interaction with the ventral striatum
28. Ultrastructural localization of D1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervation
29. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors
30. + channels by D1-like dopamine receptors in rat hippocampal neurons
31. Chronic L-dopa treatment in the unilateral 6-OHDA rat: Evidence for behavioral sensitization and biochemical tolerance
32. Pavlovian conditioning of L-dopa induced movement
33. Cocaine conditioning and cocaine sensitization: What is the relationship?
34. Regulation of cocaine reward by CREB
35. Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections
36. A transient, neuron-wide form of CREB-mediated long-term facilitation can be stabilized at specific synapses by local protein synthesis
37. Transection of corticostriatal afferents reduces amphetamine- and apomorphine-induced striatal Fos expression and turning behaviour in unilaterally 6-hydroxydopamine-lesioned rats
38. Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: Contribution of calcium conductances
39. Context-specific morphine tolerance on the paw-pressure and tail-shock vocalization tests: Evidence of associative tolerance without conditioned compensatory responding
40. NAC-1, a rat brain mRNA, is increased in the nucleus accumbens three weeks after chronic cocaine self-administration
41. In vivo activity-dependent plasticity at cortico-striatal connections: Evidence for physiological long-term potentiation
42. Role of conditioning factors in the development of drug dependence
43. Reserpine increases Fos activity in the rat basal ganglia via a quinpirole-sensitive mechanism
44. Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation
45. D1 dopamine receptor activation of multiple transcription factor genes in rat striatum
46. Neuronal adaptation to amphetamine and dopamine: Molecular mechanisms of prodynorphin gene regulation in rat striatum
47. Effects of repeated amphetamine treatment on the locomotor activity of the dopamine D1A-deficient mouse
48. Priming of D1-dopamine receptor responses: Long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats
49. Behavioral complications of drug treatment of Parkinson's disease
50. Transient amelioration of the sensitization of cocaine-induced behaviors in rats by the induction of tolerance
51. NMDA and D1 receptors regulate the phosphorylation of CREB and the induction of c-fos in striatal neurons in primary culture
52. Stress-induced sensitization and glucocorticolds. I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion
53. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use
54. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
55. Chronic D-amphetamine in nucleus accumbens: Lack of tolerance or reverse tolerance of locomotor activity
56. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine
57. Altered striatal function in a mutant mouse lacking D1A dopamine receptors
58. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons
59. Internalization of D1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists
60. Conditioned responses to cocaine-related stimuli in cocaine abuse patients
61. Amphetamine stereotypy: The influence of environmental factors and prepotent behavioral patterns on its topography and development
62. Dendritic spine changes associated with hippocampal long-term synaptic plasticity
63. The basolateral amygdala-ventral striatal system and conditioned place preference: Further evidence of limbic-striatal interactions underlying reward-related processes
64. Substantia nigra
65. Ballistic and corrective movements on an aiming task. Intention tremor and parkinsonian movement disorders compared
66. Activation of arc, a putative 'effector' immediate early gene, by cocaine in rat brain
67. Synaptic tagging and long-term potentiation
68. Synaptic tagging: Implications for late maintenance of hippocampal long-term potentiation
69. Dopaminergic antagonists prevent long-term maintenance of posttetanic LTP in the CA1 region of rat hippocampal slices
70. The effect of dopaminergic D1 receptor blockade during tetanization on the expression of long-term potentiation in the rat CA1 region in vitro
71. Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons
72. Influence of actinomycin D, an RNA synthesis inhibitor, on long-term potentiation in rat hippocampal neurons in vivo and in vitro
73. Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation
74. Cocaine addiction: Psychology and neurophysiology
75. Cocaine dependence
76. The basal ganglia
77. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons
78. D1 and D2 dopamine receptor function in the striatum: Coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons
79. Non-contingent electric footshock facilitates the acquisition of intravenous cocaine self-administration in rats
80. Circuitry of primate prefrontal cortex and regulation of behavior by representational memory
81. Cellular basis of working memory
82. Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo
83. The basal ganglia and chunking of action repertoires
84. Synaptic runaway in associative networks and the pathogenesis of schizophrenia
85. Drugs of abuse and immediate-early genes in the forebrain
86. A computational model of the progression of Alzheimer's disease
87. Neurotoxic lesions of basolateral, but not central, amygdala interfere with Pavlovian second-order conditioning and reinforcer devaluation effects
88. Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine
89. Specificity in the projection patterns of accumbal core and shell in the rat
90. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens
91. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons
92. 2+ conductance
93. G protein-coupled mechanisms and nervous signaling
94. Sensitization to the behavioral effects of cocaine: Modification by Pavlovian conditioning
95. Behavioral and neurochemical sensitization following cocaine self- administration
96. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments
97. A model of how the basal ganglia generate and use neural signals that predict reinforcement
98. Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors
99. D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus
100. Molecular alterations in the neostriatum of human cocaine addicts
101. Addiction to cocaine and amphetamine
102. 2+ stimulation of CREB-dependent transcription and ERK nuclear translocation
103. Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age
104. Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway
105. Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway
106. Chronic pharmacological manipulation of dopamine receptors in brain
107. Animals predisposed to develop amphetamine self-administration show higher susceptibility to develop contextual conditioning of both amphetamine-induced hyperlocomotion and sensitization
108. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals
109. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
110. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine
111. 2+- and calmodulin-dependent phosphorylation and synaptic vesicles
112. Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801
113. DNQX blockade of amphetamine behavioral sensitization
114. Paradoxical kinesia in parkinsonism is not caused by dopamine release. Studies in an animal model
115. Dopamine and conditioned reinforcement. I. Differential effects of amphetamine microinjections into striatal subregions
116. Responsereinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core
117. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum
118. Expression of the transcription factor ΔFosB in the brain controls sensitivity to cocaine
119. Prominence of the dopamine D2 short isoform in dopaminergic pathways
120. Nicotine induced c-fos expression in the striatum is mediated mostly by dopamine D1 receptor and is dependent on NMDA stimulation
121. Activity of primate putamen neurons is selective to the mode of voluntary movement: Visually guided, self-initiated or memoryguided
122. Connectivity and convergence of single corticostriatal axons
123. A neostriatal habit learning system in humans
124. Simultaneous LTP of non-NMDA- and LTD of NMDA-receptor-mediated responses in the nucleus accumbens
125. Haloperidol-induced Fos expression in striatum is dependent upon transcription factor cyclic AMP response element binding protein
126. Amphetamine regulates gene expression in rat striatum via transcription factor CREB
127. Amphetamine- and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium
128. Drug abuse: Hedonic homeostatic dysregulation
129. Substance dependence as a compulsive behavior
130. Neuroscience of addiction
131. A kinase to remember: Dual roles for MAP kinase in long-term memory
132. Facilitating effects of pre- and posttrial amphetamine administration on discrimination learning in mice
133. Amphetamine, cocaine, and fencamfamine: Relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics
134. Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments
135. Effects of interdose interval on ambulatory sensitization to methamphetamine, cocaine and morphine in mice
136. Inhibitory effect of restraint on induction of behavioral sensitization to methamphetamine and cocaine in mice
137. Effects of postmethamphetamine treatment with restraint on ambulatory sensitization to methamphetamine in mice
138. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity
139. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey
140. D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum
141. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors
142. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites
143. The action of central nervous system drugs: A general theory concerning amphetamine effects
144. Cocaine alters cerebral metabolism within the ventral striatum and limbic cortex of monkeys
145. Coping and the stress-induced potentiation of stimulant stereotypy in the rat
146. NMDA-receptor-dependent synaptic plasticity: Multiple forms and mechanisms
147. Dopamine receptor expression in the central nervous system
148. Postcocaine anhedonia. An animal model of cocaine withdrawal
149. Nigrostriatal bundle damage and the lateral hypothalamic syndrome
150. Activation-induced restoration of sensorimotor functions in rats with dopamine-depleting brain lesions
151. MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term facilitation in Aplysia
152. Synapse-specific, long-term facilitation of Aplysia sensory to motor synapses: A function for local protein synthesis in memory storage
153. Dopamine D1-deficient mutant mice do not express the late phase of hippocampal long-term potentiation
154. Why there are complementary learning systems in the hippocampus and neocortex: Insights from the successes and failures of connectionist models of learning and memory
155. Topographical organization of amygdaloid projections to the caudatoputamen, nucleus accumbens, and related striatal-like areas of the rat brain
156. A triple dissociation of memory systems: Hippocampus, amygdala, and dorsal striatum
157. The organization of the projection from the cerebral cortex to the striatum in the rat
158. Effects of cocaine on dopamine receptor gene expression: A study in the postmortem human brain
159. Effects of dopamine depletion on the morphology of medium spiny neurons in the shell and core of the rat nucleus accumbens
160. Cognitive neuroscience and the study of memory
161. Memories and habits: Two neural systems
162. From motivation to action: Functional interface between the limbic system and the motor system
163. Conditioning of pre- and post-synaptic behavioural responses to the dopamine receptor agonist apomorphine in rats
164. Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor
165. Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning
166. Molecular and cellular basis of addiction
167. Molecular mechanisms of drug addiction: Adaptations in signal transduction pathways
168. Molecular biology of dopamine receptors
169. A macromolecular synthesis-dependent late phase of long-term potentiation requiring cAMP in the medial perforant pathway of rat hippocampal slices
170. Requirement of a critical period of transcription for induction of a late phase of LTP
171. Myths about the treatment of addiction
172. Classical conditioning in drug-dependent humans
173. Synaptic clustering of AMPA receptors by the extracellular immediate-early gene product Narp
174. An algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines. American Academy of Neurology
175. D1/D5 dopamine receptors inhibit depotentiation at CA1 synapses via cAMP-dependent mechanism
176. Inactivation of hippocampus or caudate nucleus with lidocaine differentially affects expression of place and response learning
177. Amygdala modulation of hippocampal-dependent and caudate nucleus-dependent memory processes
178. Conditioned grooming induced by the dopamine D1-like receptor agonist SKF 38393 in rats
179. Conditioned locomotor-activating and reinforcing effects of discrete stimuli paired with intraperitoneal cocaine
180. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease
181. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats
182. Synaptic plasticity in an in vitro slice preparation of the rat nucleus accumbens
183. Conditioning as a critical determinant of sensitization induced by psychomotor stimulants
184. The benzodiazepine withdrawal syndrome
185. Pathophysiological basis of vulnerability to drug abuse: Role of an interaction between stress, glucocorticoids, and dopaminergic neurons
186. Factors that predict individual vulnerability to amphetamine self-administration
187. Conditioning of the activity effects of drugs
188. A circuitry model of the expression of behavioral sensitization to amphetamine-like psycho-stimulants
189. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge
190. Intermittent versus continuous stimulation: Effect of time interval on the development of sensitization or tolerance
191. Dopamine D1 and D2 antagonists attenuate amphetamine-produced enhancement of responding for conditioned reward in rats
192. Stereotyped activities produced by amphetamine in several animal species and man
193. Opiate withdrawal and the rat locus coeruleus: Behavioral, electrophysiological, and biochemical correlates
194. Is the shortlatency dopamine response too short to signal reward error?
195. Limbic-striatal interactions in reward-related processes
196. Neurobehavioural mechanisms of reward and motivation
197. Drug addiction: Bad habits add up
198. The neuropsychological significance of stereotypy induced by stimulant drugs
199. Neural systems underlying arousal and attention. Implications for drug abuse
200. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons
201. Narcotic use in southeast Asia and afterward. An interview study of 898 Vietnam returnees
202. Interactions of dopamine receptors with G-proteins
203. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
204. The neural basis of drug craving: An incentive-sensitization theory of addiction
205. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine
206. Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: Sex differences
207. The orbitofrontal cortex
208. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site
209. Higher and longer stress-induced increase in dopamine concentrations in the nucleus accumbens of animals predisposed to amphetamine self-administration. A microdialysis study
210. Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone
211. The effects of psychomotor stimulants on stereotypy and locomotor activity in socially-deprived and control rats
212. Procedural learning and neostriatal dysfunction in man
213. Behavioral and biochemical evidence of opioidergic involvement in cocaine sensitization
214. The behavioral neurochemistry of motivation: Methodological and conceptual issues in studies of the dynamic activity Of nucleus accumbens dopamine
215. Behavioral functions of nucleus accumbens dopamine: Empirical and conceptual problems with the anhedonia hypothesis
216. Conditioned dopaminergic activity
217. Activation of dopaminergic D1 receptors promotes morphogenesis of developing striatal neurons
218. Differentiative effects of dopamine on striatal neurons involve stimulation of the cAMP/PKA pathway
219. The phasic reward signal of primate dopamine neurons
220. Predictive reward signal of dopamine neurons
221. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task
222. Context-dependent activity in primate striatum reflecting past and future behavioral events
223. Reward-related signals carried by dopamine neurons
224. A neural substrate of prediction and reward
225. Effects of mood, motivation, stress and alertness on the performance in Parkinson's disease
226. In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment
227. Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens
228. Molecular mechanisms of drug reinforcement and addiction
229. Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists
230. Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation
231. In vivo expression and regulation of Elk-1, a target of the extracellular-regulated kinase signaling pathway, in the adult rat brain
232. Stress reinstates heroin-seeking in drug-free animals: An effect mimicking heroin, not withdrawal
233. First lapses to smoking: Within-subjects analysis of real-time reports
234. Sensitization to the conditioned rewarding effects of cocaine: Pharmacological and temporal characteristics
235. Sensitization to the behavioral effects of cocaine: Modulation by dynorphin and kappa-opioid receptor agonists
236. Examination of the neurochemical substrates mediating the motivational effects of opioids: Role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors
237. CREB and memory
238. Sensitization and conditioned rotation: Apomorphine, quinpirole and SKF-38393 compared
239. Persistent behavioural effect in apomorphine in 6-hydroxydopamine-lesioned rats
240. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway
241. Regulation of kappa opioid receptor mRNA in the rat brain by 'binge' pattern cocaine administration and correlation with preprodynorphin mRNA
242. Cocaine's time action profile on regional cerebral blood flow in the rat
243. Dynorphin regulates D1 dopamine receptor-mediated responses in the striatum: Relative contributions of pre- and postsynaptic mechanisms in dorsal and ventral striatum demonstrated by altered immediate-early gene induction
244. Membrane potential synchrony of simultaneously recorded striatal spiny neurons in vivo
245. Neurobiology of conditioning to drugs of abuse
246. Role of unconditioned and conditioned drug effects in the self- administration of opiates and stimulants
247. Robustness of G protein changes in cocaine sensitization shown with immunoblotting
248. D1 and D2 dopamine receptor modulation of sodium and potassium currents in rat neostriatal neurons
249. Reinforcement Learning
250. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function
251. Differential regulation of dopamine D1A receptor responsiveness by various G protein-coupled receptor kinases
252. A cognitive model of drug urges and drug-use behavior: Role of automatic and nonautomatic processes
253. Amphetamine-induced conditioned activity and sensitization: The role of habituation to the test context and the involvement of Pavlovian processes
254. Measuring reward with the conditioned place preference paradigm: A comprehensive review of drug effects, recent progress and new issues
255. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system
256. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: An in vivo microdialysis study in the rat
257. D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area
258. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: Lack of conditioned effects
259. Benzodiazepine side effects: Role of pharmacokinetics and pharmacodynamics
260. Dissociation of visual and olfactory conditioning in the neostriatum of rats
261. Neurotransmitter regulation of MAP kinase signaling in striatal neurons in primary culture
262. A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin messenger RNA expression in rat forebrain
263. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration
264. Effect of nigrostriatal dopamine depletion on the post-training, memory-improving action of amphetamine
265. Reward or reinforcement: What's the difference?
266. Addictive drugs as reinforcers: Multiple partial actions on memory systems
267. Mnemonic functions of the basal ganglia
268. The psychobiology of reinforcers
269. Cellular models of reinforcement
270. Dopamine reverses the depression of rat corticostriatal synapses which normally follows high-frequency stimulation of cortex in vitro
271. Addictive drugs and brain stimulation reward
272. A psychomotor stimulant theory of addiction
273. The frontal cortex-basal ganglia system in primates
274. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants
275. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine
276. Relative roles of ventra striatal D1 and D2 dopamine receptors in responding with conditioned reinforcement
277. Cocaine self-administration: Pharmacology and behavior
278. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase
279. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice
280. Egr3/Pilot, a zinc finger transcription factor, is rapidly regulated by activity in brain neurons and colocalizes with egr1/zif268
281. Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors
282. Whole-cell plasticity in cocaine withdrawal: Reduced sodium currents in nucleus accumbens neurons
283. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic